Cargando…
MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
Hepatocellular carcinoma (HCC) patients with bone metastasis (BM) suffer from pain and other symptoms that significantly reduce their quality of life. We screened a microRNA (miRNA) microarray to identify potential serum biomarkers for BM in HCC patients. A miRNA microarray was used to screen for BM...
Autores principales: | Xiang, Zuo-Lin, Zhao, Xiao-Mei, Zhang, Li, Yang, Ping, Fan, Jia, Tang, Zhao-You, Zeng, Zhao-Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349985/ https://www.ncbi.nlm.nih.gov/pubmed/27893432 http://dx.doi.org/10.18632/oncotarget.13531 |
Ejemplares similares
-
Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
por: Xiang, Zuo-Lin, et al.
Publicado: (2019) -
A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2015) -
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
por: Zhang, Li, et al.
Publicado: (2021) -
The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2019) -
Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma
por: Bharali, Dipu, et al.
Publicado: (2018)